BNC105P
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BNC105P, covering 2015-12-23 to 2017-05-24. Get the full timeline:
Most recent: Clinical Trial Update: BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Phase 1, Phase 2]